LG AI Research Partners with D&D Pharmatech to Revolutionize Oral Peptide Drug Development#South_Korea#Seoul#LG_AI_Research#D&D_Pharmatech#oral_peptides
LG AI Research Partners with D&D Pharmatech to Revolutionize Oral Peptide Drug Development
A new collaboration between LG AI Research and D&D Pharmatech aims to innovate the next generation of oral peptide drugs using advanced AI technologies. The partnership promises to accelerate drug discovery processes dramatically.
third-news.com
June 17, 2026 at 2:51 PM
LG AI Research Partners with D&D Pharmatech to Revolutionize Oral Peptide Drug Development#South_Korea#Seoul#LG_AI_Research#D&D_Pharmatech#oral_peptides
AI Analysis by HistoIndex Shows Significant Improvement in Liver Fibrosis with D&D Pharmatech's Zabopegdutide#Singapore#HistoIndex#D&D_Pharmatech#Zabopegdutide
AI Analysis by HistoIndex Shows Significant Improvement in Liver Fibrosis with D&D Pharmatech's Zabopegdutide
HistoIndex's innovative AI analysis highlights major improvements in liver fibrosis treatment through D&D Pharmatech's Zabopegdutide in their Phase 2 trial.
third-news.com
June 18, 2026 at 2:16 AM
AI Analysis by HistoIndex Shows Significant Improvement in Liver Fibrosis with D&D Pharmatech's Zabopegdutide#Singapore#HistoIndex#D&D_Pharmatech#Zabopegdutide